These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 29940352)
1. The cysteine-rich whey protein supplement, Immunocal®, preserves brain glutathione and improves cognitive, motor, and histopathological indices of traumatic brain injury in a mouse model of controlled cortical impact. Ignowski E; Winter AN; Duval N; Fleming H; Wallace T; Manning E; Koza L; Huber K; Serkova NJ; Linseman DA Free Radic Biol Med; 2018 Aug; 124():328-341. PubMed ID: 29940352 [TBL] [Abstract][Full Text] [Related]
2. Immunocal® limits gliosis in mouse models of repetitive mild-moderate traumatic brain injury. Koza LA; Pena C; Russell M; Smith AC; Molnar J; Devine M; Serkova NJ; Linseman DA Brain Res; 2023 Jun; 1808():148338. PubMed ID: 36966959 [TBL] [Abstract][Full Text] [Related]
3. Cysteine-rich whey protein isolate (Immunocal®) ameliorates deficits in the GFAP.HMOX1 mouse model of schizophrenia. Song W; Tavitian A; Cressatti M; Galindez C; Liberman A; Schipper HM Free Radic Biol Med; 2017 Sep; 110():162-175. PubMed ID: 28603087 [TBL] [Abstract][Full Text] [Related]
4. Effect of cysteine-rich whey protein (immunocal®) supplementation in combination with resistance training on muscle strength and lean body mass in non-frail elderly subjects: a randomized, double-blind controlled study. Karelis AD; Messier V; Suppère C; Briand P; Rabasa-Lhoret R J Nutr Health Aging; 2015 May; 19(5):531-6. PubMed ID: 25923482 [TBL] [Abstract][Full Text] [Related]
5. A Cystine-Rich Whey Supplement (Immunocal®) Provides Neuroprotection from Diverse Oxidative Stress-Inducing Agents Winter AN; Ross EK; Daliparthi V; Sumner WA; Kirchhof DM; Manning E; Wilkins HM; Linseman DA Oxid Med Cell Longev; 2017; 2017():3103272. PubMed ID: 28894506 [TBL] [Abstract][Full Text] [Related]
6. A Cystine-Rich Whey Supplement (Immunocal(®)) Delays Disease Onset and Prevents Spinal Cord Glutathione Depletion in the hSOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis. Ross EK; Winter AN; Wilkins HM; Sumner WA; Duval N; Patterson D; Linseman DA Antioxidants (Basel); 2014 Dec; 3(4):843-65. PubMed ID: 26785244 [TBL] [Abstract][Full Text] [Related]
7. Treatment of traumatic brain injury in rats with N-acetyl-seryl-aspartyl-lysyl-proline. Zhang Y; Zhang ZG; Chopp M; Meng Y; Zhang L; Mahmood A; Xiong Y J Neurosurg; 2017 Mar; 126(3):782-795. PubMed ID: 28245754 [TBL] [Abstract][Full Text] [Related]
8. A novel antagonist of p75NTR reduces peripheral expansion and CNS trafficking of pro-inflammatory monocytes and spares function after traumatic brain injury. Lee S; Mattingly A; Lin A; Sacramento J; Mannent L; Castel MN; Canolle B; Delbary-Gossart S; Ferzaz B; Morganti JM; Rosi S; Ferguson AR; Manley GT; Bresnahan JC; Beattie MS J Neuroinflammation; 2016 Apr; 13(1):88. PubMed ID: 27102880 [TBL] [Abstract][Full Text] [Related]
11. The delayed protective effect of GK-2, а dipeptide mimetic of Nerve Growth Factor, in a model of rat traumatic brain injury. Genrikhs EE; Voronkov DN; Kapkaeva MR; Gudasheva TA; Glibka YA; Isaev NK; Stelmashook EV Brain Res Bull; 2018 Jun; 140():148-153. PubMed ID: 29730416 [TBL] [Abstract][Full Text] [Related]
13. Immunocal® and preservation of glutathione as a novel neuroprotective strategy for degenerative disorders of the nervous system. Ross EK; Gray JJ; Winter AN; Linseman DA Recent Pat CNS Drug Discov; 2012 Dec; 7(3):230-5. PubMed ID: 22742422 [TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effect of Da Chuanxiong Formula against cognitive and motor deficits in a rat controlled cortical impact model of traumatic brain injury. Liu ZK; Ng CF; Shiu HT; Wong HL; Chin WC; Zhang JF; Lam PK; Poon WS; Lau CB; Leung PC; Ko CH J Ethnopharmacol; 2018 May; 217():11-22. PubMed ID: 29425850 [TBL] [Abstract][Full Text] [Related]
15. The contribution of stem cell factor and granulocyte colony-stimulating factor in reducing neurodegeneration and promoting neurostructure network reorganization after traumatic brain injury. He J; Russell T; Qiu X; Hao F; Kyle M; Chin L; Zhao LR Brain Res; 2020 Nov; 1746():147000. PubMed ID: 32579949 [TBL] [Abstract][Full Text] [Related]
16. Administration of Protocatechuic Acid Reduces Traumatic Brain Injury-Induced Neuronal Death. Lee SH; Choi BY; Lee SH; Kho AR; Jeong JH; Hong DK; Suh SW Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29168791 [TBL] [Abstract][Full Text] [Related]
17. Effects of long-term supplementation with whey proteins on plasma glutathione levels of HIV-infected patients. Micke P; Beeh KM; Buhl R Eur J Nutr; 2002 Feb; 41(1):12-8. PubMed ID: 11990003 [TBL] [Abstract][Full Text] [Related]
18. Acute treatment with TrkB agonist LM22A-4 confers neuroprotection and preserves myelin integrity in a mouse model of pediatric traumatic brain injury. Fletcher JL; Dill LK; Wood RJ; Wang S; Robertson K; Murray SS; Zamani A; Semple BD Exp Neurol; 2021 May; 339():113652. PubMed ID: 33609501 [TBL] [Abstract][Full Text] [Related]
19. Low-Field Magnetic Stimulation Restores Cognitive and Motor Functions in the Mouse Model of Repeated Traumatic Brain Injury: Role of Cellular Prion Protein. Sekar S; Zhang Y; Miranzadeh Mahabadi H; Parvizi A; Taghibiglou C J Neurotrauma; 2019 Nov; 36(22):3103-3114. PubMed ID: 31020907 [TBL] [Abstract][Full Text] [Related]